It can block, in a dose-dependent manner, PDGFRα and PDGFRβ phosphorylation upon stimulation with PDGF-AA and/or PDGF-BB in SSc and healthy control dermal fibroblast and can inhibit their proliferation and migration in vitro. Here, PDGFRB is linked to systemic sclerosis.